Centre de Référence
des Maladies Autoinflammatoires
et des Amyloses

 
 
 
 
 
 

Publications

In press

ADVERSE EVENTS AND LONG-TERM SAFETY OF TREATMENTS IN AUTOINFLAMMATORY DISEASES: REAL
LIFE DATA FROM THE EUROFEVER REGISTRY

Yulia Vyzhga, Joost Frenkel, Antonella Insalaco, Jordi Anton , Isabelle Koné-Paut, Elizabeth Legger, Giovanna Fabio, Marco Cattalini, Sylvia Kamphuis, Eric Hachulla, Karoline Krause11, Zelal Ekinci, Judith Sanchez Manubens, J.Merlijn Van den Berg, Cristina Herrera Mora, Petra Hissink Muller , Eztizen Labrador, Judith Potjewijd, Luca Carlini, Marta Bustaffa, Roberta Caorsi, Nicolino Ruperto, Marco Gattorno for Eurofever and the Paediatric Rheumatology International Trials Organisation (PRINTO)
J CLIN IMMUNOL - 2024

Pediatric non-infectious granulomatous uveitis: a retrospective cohort study
Nguyen, Ai Tien; rousseau, antoine; Bodaghi, Bahram; Rossi-Semerano, Linda; Galeotti, Caroline; Da Cunha, Elodie; Eid, Laura; Labetoulle, Marc; Barreau, Emmanuel; Titah, Cherif; Toutée, Adélaïde; Koné-Paut, Isabelle; Dusser, Perrine; Borocco, Charlotte.
RHEUMATOLOGY (Oxford) - 2024

Fièvre Méditerranéenne Familiale : nouveaux phénotypes et mécanismes génétiques
Martin Broly, Guilaine Boursier, Isabelle Touitou*
BULL ACAD NATL MED - 2023

Maladies auto-inflammatoires de l’enfant : apport de la génétique
Guilaine Boursier, Isabelle Touitou
REV PRAT - 2023

A comparative clinical trial to assess a standardized escalation dose strategy of interleukin-1 blockade in Kawasaki disease: The ANACOMP trial
Koné-Paut I, Toumazi A, Bourmaud A
CLIN INVESTIG (LOND) - 2021

 

2024 Voir une autre année ?

[Genetic mosaicism in Systemic Auto-Inflammatory Diseases: A review of the literature].
Parentelli AS, Boursier G, Cuisset L, Georgin-Lavialle S.
Rev Med Interne, 2024 May 17. pii: S0248-8663(24)00566-6. doi: 10.1016/j.revmed.2024.05.003. Epub 2024 May 17.

Canakinumab treatment real world evidence in 3 monogenic periodic fever syndromes in 2009-2022: an interim analysis using the French JIR cohort database.
Koné-Paut I, Georgin-Lavialle S, Belot A, Jover M, Pouriel M, Lacoin L, Pillet P, Hentgen V.
Arthritis Res Ther, 2024 Apr 8. 26(1):80. doi: 10.1186/s13075-024-03316-7. Epub 2024 Apr 8.

Functional diversity of NLRP3 gain-of-function mutants associated with CAPS autoinflammation.
Cosson C, Riou R, Patoli D, Niu T, Rey A, Groslambert M, De Rosny C, Chatre E, Allatif O, Henry T, Venet F, Milhavet F, Boursier G, Belot A, Jamilloux Y, Merlin E, Duquesne A, Grateau G, Savey L, Jacques Maria AT, Pagnier A, Poutrel S, Lambotte O, Mallebranche C, Ardois S, Richer O, Lemelle I, Rieux-Laucat F, Bader-Meunier B, Amoura Z, Melki I, Cuisset L, Touitou I, Geyer M, Georgin-Lavialle S, Py BF.
J Exp Med, 2024 May 6. doi: 10.1084/jem.20231200. Epub 2024 Mar 26.

Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis.
Brunner HI, Ruperto N, Ramanan AV, Horneff G, Minden K, Calvo Penades I, Alexeeva E, Cleary G, Stern SM, Kone-Paut I, Maldonado Velázquez MDR, Rabinovich CE, Remesal A, Silva CA, Nikishina I, Zucchetto M, Brockwell L, Gordon O, Nagel S, De Benedetti F, PRINTO and PRCSG investigators.
Rheumatology (Oxford), 2024 Mar 29. pii: keae180. doi: 10.1093/rheumatology/keae180. Epub 2024 Mar 29.

Pyrin-associated autoinflammatory disease with p.Thr577Ala MEFV somatic mutation.
Terré A, Magnotti F, Piot JM, Boursier G, Georgin-Lavialle S.
Eur J Intern Med, 2024 Feb. doi: 10.1016/j.ejim.2023.11.014. Epub 2023 Nov 18.

Subcutaneous anakinra in the management of refractory MIS-C in France.
Dusser P, Belot A, Bajolle F, Kevorkian-Verguet C, Meinzer U, Huet F, Tiriau S, Kone-Paut I.
Front Pediatr, 2024. doi: 10.3389/fped.2024.1270878. Epub 2024 Feb 23.